Sunday, January 27, 2013

Top Stocks For 1/27/2013-8

EQ Labs (Pink Sheets:EQLB) announced today that it began a national advertising campaign with a 5 minute spot on ABC affiliate KTNV (Channel 13) in Las Vegas. Chief Executive Officer, Maurice Owens, was featured on “The Morning Blend” show talking about the virtues of EQ Energy drink while also displaying the company’s complete product line.

KTNV is owned by New York Stock Exchange-traded Journal Communications, Inc. The Company owns television stations, radio stations and newspapers in Arizona, Wisconsin, California, Florida and other major markets throughout the country.

In the interview, Owens stresses the health factor of EQ, “No sugar, five calories.”

Owens continued, “The flavors are super. We have Mo Apple and Strawberry Dream. It takes about 30 seconds to get going.”

Chief Executive Officer Owens also stated that the market for EQ is very large and that he expects EQ Energy drink to be in 5,000 additional stores by year end as the company’s products are already in 45 states. Owens stated that the “Healthy Energy Drink” is being used by students, truck drivers and young adults because of its wide spread appeal.

Owens added toward the end of the interview, “We have three top distributors so we have access to about 150,000 stores.”

EQ Labs is engaged in the development, marketing and sale of EQ (“The Smart Energy Drink”). EQ is an effervescent tablet that can be dissolved in any beverage to provide instant energy. Consisting of a blend of essential vitamins, Gingko Biloba, and less caffeine than a cup of coffee. EQ is currently sold at Best Buy, 7-Eleven, Walgreens and other leading retailers.

PepsiCo (NYSE: PEP), the world’s second-largest food and beverage business, and Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, have entered into a four-year collaborative agreement related to Senomyx’s sweet-taste technology.

PepsiCo’s collaboration with Senomyx will focus on the discovery, development and commercialization of sweet enhancers and natural high-potency sweeteners with the intent to bring to the marketplace lower-calorie, great tasting PepsiCo beverages. The agreement reflects the companies’ shared commitment to offer healthier products to consumers that maintain the sweet taste they want.

“This relationship with Senomyx reflects our increasingly long-term approach to research and development as well as our belief that global food and beverage companies can play an important role in identifying new ingredients that can lead to healthier products,” said Mehmood Khan, PepsiCo’s chief scientific officer. “The real challenge is to create products that not only are healthier but also taste great, and Senomyx has unique technologies that will allow us to improve the nutritional profile of our products without sacrificing taste. We’re very optimistic that this collaboration will help us achieve our commitment to reduce added sugar per serving by 25% in key brands in key markets over the next decade and ultimately help people around the world live healthier lives.”

“We are looking forward to working with PepsiCo on our common objective of developing products that meet the growing demand for lower-calorie offerings,” stated Kent Snyder, chief executive officer of Senomyx. “PepsiCo is an industry leader with its commitment to reducing added sugar in key global beverage brands, and we are particularly excited about expanding our research efforts for the discovery of enhancers of sweeteners such as sucrose and fructose and the identification of new natural high-potency sweeteners that would allow Senomyx to provide PepsiCo with a broad spectrum of sweet- taste options.”

PepsiCo will have exclusive rights to the Senomyx sweet flavor ingredients developed under the collaboration for use in non-alcoholic beverage categories. Under the agreement, Senomyx will receive an upfront payment of $30 million from PepsiCo, $7.5 million of which was paid previously. Senomyx also will be entitled to $32 million in committed research and development payments over the four-year research period. PepsiCo retains the option to extend the research collaboration for two more years, which would result in additional research funding commitments. Senomyx also will be eligible for milestone payments based on the achievement of predetermined goals as well as royalty payments.

Senomyx (Nasdaq: SNMX) is discovering and developing innovative flavor ingredients for the food, beverage, and ingredient supply industries using our unique proprietary technologies. Senomyx believes that their novel flavors, flavor enhancers, and bitter blockers will enable collaborators to achieve a competitive advantage and/or improve the nutritional profile of their products while maintaining or enhancing taste.

The Company’s key flavor programs focus on the discovery and development of savory, sweet and salt flavor ingredients that are intended to allow for the reduction of MSG, sugar and salt in food and beverage products. In addition, Senomyx has a bitter blocker program to reduce or block bitter tastes and thereby improve the taste characteristics of foods, beverages and pharmaceutical products. Senomyx also has a cool flavor program for the discovery of novel flavor ingredients intended to provide a cooling taste effect for confectioneries, foods and beverages, as well as oral care and OTC healthcare products.

Senomyx has four savory flavor ingredients that were discovered and developed in-house and have received regulatory approval in the U.S. and many additional countries. Nestl� is currently marketing products that contain one of Senomyx’s Savory Flavor Ingredients in the Pacific Rim and Latin America.

Senomyx has entered into product discovery and development collaborations with some of the world’s leading food, beverage, and ingredient supply companies: PepsiCo, Ajinomoto Co., Inc., Campbell Soup Company, Firmenich SA, Nestl� SA and Solae. These collaborations provide Senomyx with research and development funding, milestone payments based upon achievement of research or development goals, and royalties on sales of products incorporating our flavor ingredients.

No comments:

Post a Comment